Allergan Glaucoma Therapy Combigan Available In Q4
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm gains FDA approval of treatment to reduce elevated intraocular pressure after three “approvable” letters.
You may also be interested in...
Allergan Adds To Growth Areas With Acquisition Of Eye-Disease Compounds
Deal with UK’s Asterand nets preclinical prostaglandin receptor agonists with potential in glaucoma, other eye conditions.
Allergan Adds To Growth Areas With Acquisition Of Eye-Disease Compounds
Deal with UK’s Asterand nets preclinical prostaglandin receptor agonists with potential in glaucoma, other eye conditions.
Allergan Memantine Filing Delay Anticipated Following Phase III Results
Company awaits results from a second trial evaluating the neuroprotective agent in prevention of vision loss.